Abstract Number: 1130 • 2018 ACR/ARHP Annual Meeting
Chronic Risk Factors for Recurrent Gout Flares Among Established Gout Patients: A Prospective Cohort Analysis
Background/Purpose: Understanding the risk factors for recurrent flares among established gout patients is directly relevant to clinical care; however, relevant data are scarce. A previous…Abstract Number: 1131 • 2018 ACR/ARHP Annual Meeting
The Prevalence and Incidence of Gout, Its Associated Comorbidities and Treatment Pattern: An Epidemiological Study from Germany
Background/Purpose: The most common type of inflammatory arthritis in Germany is gout, however the last epidemiological study was done a decade ago (Annemanns, 2007). This…Abstract Number: 1132 • 2018 ACR/ARHP Annual Meeting
Diet Modification for Gout Patients: Effects on Gout Attacks and Risk Factors for Metabolic Syndrome
Background/Purpose: Gout affects 8 million individuals in the US and is prevalent among patients with metabolic syndrome. Although there are many medications to control gout…Abstract Number: 1149 • 2018 ACR/ARHP Annual Meeting
Contemporary Prevalence of Gout and Hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015-2016) and Decadal Trends (NHANES 2007-2016)
Background/Purpose: The prevalences of gout and hyperuricemia from the National Health and Nutrition Examination Survey (NHANES) 2007-2008 were 3.9% (8.3 million) and 21.4% (43.3 million…Abstract Number: 1204 • 2018 ACR/ARHP Annual Meeting
Experience Matters in Ultrasound Assessment of Gout
Background/Purpose: Ultrasound has emerged in the field of rheumatology as a diagnostic aid for gout and other similar forms of arthritis. While a number of…Abstract Number: 1247 • 2018 ACR/ARHP Annual Meeting
Pharmacist-Managed Titration of Urate-Lowering Therapy to Streamline Gout Management
Background/Purpose: The treat-to-target approach for serum uric acid is the recommended model in gout management according to the 2012 American College of Rheumatology (ACR) guidelines.…Abstract Number: 1260 • 2018 ACR/ARHP Annual Meeting
Predictors of Hospitalization Due to Acute Gout: A Retrospective Cohort Study
Background/Purpose: Despite effective treatments, hospitalization due to acute gout is increasing and is financially burdensome. Prior studies have primarily attributed the increased rate of gout…Abstract Number: 1265 • 2018 ACR/ARHP Annual Meeting
The Challenges of Managing Gout in Primary Care: Results of a Best Practice Audit
Background/Purpose: The majority of gout management occurs in primary care and may be suboptimal. While community based clinical trials have reported improvements whether such improvements…Abstract Number: 1266 • 2018 ACR/ARHP Annual Meeting
ABCG2 rs2231142 Q141K and Oxypurinol Concentration in People with Gout Receiving Allopurinol
Background/Purpose: Association of ABCG2 Q141K (p.141Lys) with poor urate-lowering response to allopurinol has been reported although the mechanism is unclear. ABCG2 has been reported to…Abstract Number: 1271 • 2018 ACR/ARHP Annual Meeting
Predictive Factors of Increased Vascular Stiffness in Patient with Gout and Hyperuricemia
Background/Purpose: Background: Gout is the most common form of inflammatory arthritis and its prevalence is increasing in more affluent countries in recent decades. Many studies…Abstract Number: 1272 • 2018 ACR/ARHP Annual Meeting
Quality of Gout Management in a Rheumatology Clinic Using a Provider-Pharmacist Team-Based Approach
Background/Purpose: Gout is the most common form of inflammatory arthritis.1 The cornerstone of treatment for gout is urate-lowering therapy (ULT), which in the U.S. includes…Abstract Number: 1273 • 2018 ACR/ARHP Annual Meeting
What Did Patients from the US Think about Their Gout in 2017?
Background/Purpose: The impact of chronic gout and acute flares on daily activities is severely limiting. Yet only 40% of gout patients receive urate-lowering therapy (ULT),…Abstract Number: 1274 • 2018 ACR/ARHP Annual Meeting
Atmospheric Temperature and the Incidence of Gout Flare: Data from the Korea Meteorological Association and National Health Insurance Service
Background/Purpose: Gout management is mainly focused on life style modification and proper medications. Of note, seasonal variation of gout flare was also implemented to be…Abstract Number: 1275 • 2018 ACR/ARHP Annual Meeting
Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout
Background/Purpose: Gout is associated with joint damage, and increased cardiovascular morbidity, so to diagnose and treat gout early is important. However, joint aspiration and microscopy…Abstract Number: 1276 • 2018 ACR/ARHP Annual Meeting
Effect of Colchicine on Diabetes Incidence Among Gout Patients in a Veterans’ Affairs Population
Background/Purpose: Previous studies suggest that patients with gout are at increased risk for developing diabetes.1 One possible explanation for this increased risk is the activation…
Simple Search Results
Didn't find what you were looking for? Try the Advanced Search »
Didn't find what you were looking for? Try the Advanced Search »